THE CANNABIS INNOVATION CENTER

The Cannabis Innovation center is an Israeli biotech innovation group with a specialty in the fields of Cannabis with main strengths in the pharmaceutical space through its vast experience and activities.

 

Stero Biotechs – a pharmaceutical startup company developing a CBD-based steroid sparing treatment with a strong IP, ongoing phase 2a clinical trials with more indications in the pipeline for 2020

CannaLean Biotechs – a pharmaceutical startup company developing a novel formulation to lower the lipid blood levels in patients with dyslipidemia with 3 successful pre-clinical trials with 2 clinical trials in the pipeline at H2 of 2020

CannaMore Biotechs – a pre-clinical and clinical stage research platform company committed to the development of novel and improved cannabis-based treatment options with a groundbreaking partnership with the largest HMO in Israel with clinical trials in the pipeline for 2020

BioSeed – a biotech & Cannabis startup incubator that provides the perfect eco-system for startup companies in the vast field of Biotech and Cannabis in particular, with dedication to support early stage startups, providing them all the necessary tools guidance ,R&D support and more. BioSeedXL specializes in biotech with an emphasis on Cannabis in the fields of pharma, medical device, diagnostics, OTC and cosmetics.

CannaDu – an exclusive Biotech Venture Capital fund, focused on Cannabis investments in fields of Pharmaceuticals, wellness, medical applications & devices.

THE GROUP's CLINICAL TRIALS

#Indicationphase
1GvHD prevention2b
2Crohn's Disease2a
3Urticaria2a
4Cholesterol2a
5Paucities2a
6Bronchiolitis Obliterans treatment2a
7Triglycerides2a
8GvHD treatment2b
9COPD & Asthma /Autoimmune2a
10Ulcerative colitis2a
11Bronchiolitis Obliterans prevention2a
12GvHD  prevention3
13Arthritis2a